News

AgroSpheres Awarded Competitive SBIR Phase II Grant from the National Science Foundation to Combat Fall Armyworm

AgroSpheres, Inc. has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant for $999,653 to progress its R&D collaboration with the University of Tennessee on an RNAi biological insecticide targeting fall armyworm (FAW). Larvae of FAW are one of the most economically devastating insect pests in its native region of the tropical Americas, and is quickly becoming a global superpest threatening food security worldwide. The Phase II award from the NSF represents confidence in results demonstrating efficient RNAi in FAW and the capability of the proprietary technology platform to power in field delivery.

The FAW team at the University of Tennessee Institute of Agriculture is led by Dr. Juan Luis Jurat-Fuentes, a Professor in the Department of Entomology and Plant Pathology with more than a decade of expertise on controlling FAW with insecticidal proteins and developing RNAi against this pest. The team is enthusiastic to continue its exciting collaboration with AgroSpheres. “We are looking forward to applying our expertise on fall armyworm to further test AgroSpheres’ novel AgriCell RNAi production and delivery method to control this important crop pest,” Dr. Jurat-Fuentes says. He adds, “We have seen unprecedented RNAi activity against fall armyworm through testing the AgriCell platform in replicated lab trials and are excited to continue to the greenhouse and the field.”

“We are motivated by the vote of confidence from the NSF to develop the next generation of crop protection products, ” said Ameer Shakeel, Founder and Chief Technology Officer at AgroSpheres. “We believe we have a transformative technology for the cost-effective synthesis and delivery of RNA which has been further enhanced by integrating Orion’s Motif Fingerprinting.”

The NSF SBIR Phase II grant follows two recent grant awards to AgroSpheres. The first is from the Center for Innovative Technology’s inaugural Commonwealth Commercialization Fund (CCF) for $100,000 to support AgroSpheres’ commercial efforts. The second is from the USDA SBIR Phase I program $100,000 to fund the replacement of microplastics and petroleums in pesticide formulations. AgroSpheres is grateful for the support of the state and federal institutions.

 

Recent News

07/01/2025

ISOThrive Announces Promising Phase 2 Interim Data for Novel Heartburn Treatment and Appoints Pharma Veteran Mike Walther as Chief Strategy Officer

ISOThrive Inc., a clinical-stage biopharmaceutical company, announced interim results from a Phase 2 study of its lead candidate, ISOT-101, for treatment of Non-Erosive Reflux Disease (NERD). The data showed positive trends in addressing heartburn frequency and symptom severity among proton pump inhibitor (PPI) partial-responders (PR), a patient population with major unmet medical need. These positive

07/01/2025

Gary Lowenthal Joins Focused Ultrasound Foundation’s Council

The Focused Ultrasound Foundation is pleased to welcome Gary Lowenthal to its Council, a dedicated group of goodwill ambassadors who work closely with the Board of Directors and staff to provide advice and assist with raising funds and building awareness. Mr. Lowenthal is a retired educator, entrepreneur, and executive with a career spanning education, international service,

06/25/2025

Liquet Medical Closes Oversubscribed Seed Round to Launch Pilot Study Evaluating Real-Time Hemodynamic Monitoring

Liquet Medical, a clinical-stage medical device company developing the Versus™ Catheter — a first-of-its-kind dual-tipped catheter system cleared by the FDA for controlled and selective infusion of fluids into the pulmonary vasculature and hemodynamic monitoring — announced the successful and oversubscribed close of its Seed funding round, which officially closed in May 2025. The capital